Kiritsi D - Search Results

1

Recent advances in understanding and managing epidermolysis bullosa.

Kiritsi D, Nyström A. Kiritsi D, et al. F1000Res. 2018 Jul 17;7:F1000 Faculty Rev-1097. doi: 10.12688/f1000research.14974.1. eCollection 2018. F1000Res. 2018. PMID: 30057747 Free PMC article. Review.

2

Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa.

Kiritsi D, Kern JS, Schumann H, Kohlhase J, Has C, Bruckner-Tuderman L. Kiritsi D, et al. J Med Genet. 2011 Jul;48(7):450-7. doi: 10.1136/jmg.2010.086751. Epub 2011 Feb 28. J Med Genet. 2011. PMID: 21357940 Free article.

3

Dynamic interactions of epidermal collagen XVII with the extracellular matrix: laminin 332 as a major binding partner.

Nishie W, Kiritsi D, Nyström A, Hofmann SC, Bruckner-Tuderman L. Nishie W, et al. Among authors: kiritsi d. Am J Pathol. 2011 Aug;179(2):829-37. doi: 10.1016/j.ajpath.2011.04.019. Epub 2011 Jun 14. Am J Pathol. 2011. PMID: 21801871 Free PMC article.

4

Laminin 332 in junctional epidermolysis bullosa.

Kiritsi D, Has C, Bruckner-Tuderman L. Kiritsi D, et al. Cell Adh Migr. 2013 Jan-Feb;7(1):135-41. doi: 10.4161/cam.22418. Epub 2012 Oct 17. Cell Adh Migr. 2013. PMID: 23076207 Free PMC article. Review.

5

Molecular therapies for epidermolysis bullosa.

Has C, Kiritsi D. Has C, et al. Among authors: kiritsi d. G Ital Dermatol Venereol. 2013 Feb;148(1):65-72. G Ital Dermatol Venereol. 2013. PMID: 23407078 Review.

6

Phenotypic spectrum of epidermolysis bullosa associated with α6β4 integrin mutations.

Schumann H, Kiritsi D, Pigors M, Hausser I, Kohlhase J, Peters J, Ott H, Hyla-Klekot L, Gacka E, Sieron AL, Valari M, Bruckner-Tuderman L, Has C. Schumann H, et al. Among authors: kiritsi d. Br J Dermatol. 2013 Jul;169(1):115-24. doi: 10.1111/bjd.12317. Br J Dermatol. 2013. PMID: 23496044

7

Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa.

Kiritsi D, Garcia M, Brander R, Has C, Meijer R, Jose Escámez M, Kohlhase J, van den Akker PC, Scheffer H, Jonkman MF, Del Rio M, Bruckner-Tuderman L, Pasmooij AMG. Kiritsi D, et al. J Invest Dermatol. 2014 Aug;134(8):2097-2104. doi: 10.1038/jid.2014.118. Epub 2014 Feb 27. J Invest Dermatol. 2014. PMID: 24577406 Free article.

8

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms.

Nyström A, Thriene K, Mittapalli V, Kern JS, Kiritsi D, Dengjel J, Bruckner-Tuderman L. Nyström A, et al. Among authors: kiritsi d. EMBO Mol Med. 2015 Sep;7(9):1211-28. doi: 10.15252/emmm.201505061. EMBO Mol Med. 2015. PMID: 26194911 Free PMC article.

9

Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression.

Mittapalli VR, Madl J, Löffek S, Kiritsi D, Kern JS, Römer W, Nyström A, Bruckner-Tuderman L. Mittapalli VR, et al. Among authors: kiritsi d. Cancer Res. 2016 Feb 15;76(4):940-51. doi: 10.1158/0008-5472.CAN-15-1348. Epub 2015 Dec 16. Cancer Res. 2016. PMID: 26676755

10

The role of TGFβ in wound healing pathologies.

Kiritsi D, Nyström A. Kiritsi D, et al. Mech Ageing Dev. 2018 Jun;172:51-58. doi: 10.1016/j.mad.2017.11.004. Epub 2017 Nov 11. Mech Ageing Dev. 2018. PMID: 29132871 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page